The latest in smarter trials

As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.

An image of Martin Landray on a dark green background

Opinion 18 December 2023

Smarter clinical trials for a healthier population

Prof Sir Martin Landray writes about how clinical trials are key to common disease prevention, early detection and treatment.

An image of Martin Landray on a bright green background

Explainer 14 December 2023

Tackling common disease burden through clinical trial innovation

As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the...

News 11 October 2023

Protas gains ISO 9001 certification for high standards of quality

The international accreditation acknowledges our approach to quality.

Opinion 05 October 2023

Meet the team: Abbie Gerard, Clinical Quality Assurance Specialist

Abbie Gerard shares what motivated her to move from academia to a new not-for-profit.

News 07 September 2023

Apollo Therapeutics and Protas partner to advance therapeutic programmes

Protas will provide expertise to the portfolio biopharma on a range of drug development programmes.

An image of Esther Krofah on a dark green background

Opinion 31 August 2023

Meet the board: Esther Krofah

The Executive Vice President of Milken Institute Health shares what drew her to Protas.

An image of Venkat Rajendran on a bright green background

Opinion 16 August 2023

Meet the team: Venkatakrishnan Rajendran, Clinical Operations Manager

Venkat Rajendran shares his exciting, and sometimes unusual, career trajectory.

An image of Jonathan Solomon on a dark green background

Opinion 24 July 2023

Meet the team: Jonathan Solomon, Legal Counsel

Jonathan Solomon shares what drew him from private practice to a clinical trial not-for-profit.

News 12 June 2023

O’Shaughnessy review: Protas, Oxford and Good Clinical Trials Collaborative respond

Together, the three organisations are calling for actions not words in The Lancet.

1 2 3 4 5 6 7